MFDS — authorised 3 June 1971
- Marketing authorisation holder: DAVA PHARMS INC
- Status: likely_approved
🇰🇷 Pyrazinamide in South Korea
MFDS authorised Pyrazinamide on 3 June 1971
Marketing authorisation
Pyrazinamide in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in South Korea
Frequently asked questions
Is Pyrazinamide approved in South Korea?
Yes. MFDS authorised it on 3 June 1971.
Who is the marketing authorisation holder for Pyrazinamide in South Korea?
DAVA PHARMS INC holds the South Korean marketing authorisation.